Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1979 Aug;40(2):244–252. doi: 10.1038/bjc.1979.172

Antibody-dependent cellular cytotoxicity to human colon-tumour cells. II. Analysis of the antigens involved

J Shoham, M Cohen
PMCID: PMC2010009  PMID: 89858

Abstract

The relationship between carcinoembryonic antigen (CEA) and A antigenic determinants on the cell surface of colon-tumour cells was studied by the ADCC assay. Antiserum prepared in 2 rabbits to an undecapeptide analogous to the amino terminal of CEA(1-11) was found by us either to participate in (Rabbit 2) or specifically inhibit (Rabbit 1) ADCC. The binding spectra of these two antisera and of antiserum to the whole CEA molecule were similar. All of them react with A and non-A colon-tumour cells as well as red blood cells of Type A (RBC-A) and their activity was completely absorbed on RBC-A but not on B or O. O-type, ADCC-reactive human sera always react with A-type colon-tumour cells and RBC-A, and some of them with non-A colon-tumour cells also. The degree of inhibition of their reactivity by anti-CEA(1-11) R1 varied between sera, from none to almost a complete inhibition, and is not related to whether the serum is of cancer or non-cancer origin. Non-reactive O-type sera contain anti-A activity demonstrable by haemagglutination and immunofluorescence. However, they cannot participate in ADCC reaction nor inhibit it. The sera, which contain lymphocyte-dependent antibody to A-type colon-tumour cells, lysed RBC-A, without the addition of lymphocytes or complement, in an immunologically specific way. It is concluded that the reactivity seen in our ADCC system is related to a determinant common to A and CEA (and maybe to other normal cross-reacting antigens) which most probably resides in the amino terminal part of these molecules. This determinant elicits the production of lymphocyte-dependent antibodies in about 50% of people with blood group O. Thus, the amino terminal part of CEA is not a tumour-specific part of the CEA molecule. No specific anti-tumour activity was found in patients' serum by this method, and claims for its demonstration by other methods may well be related to the non-specific activity observed here.

Full text

PDF
244

Images in this article

250Figure
on p.250

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arnon R., Bustin M., Calef E., Chaitchik S., Haimovich J., Novik N., Sela M. Immunological cross-reactivity of antibodies to a synthetic undecapeptide analogous to the amino terminal segment of carcinoembryonic antigen, with the intact protein and with human sera. Proc Natl Acad Sci U S A. 1976 Jun;73(6):2123–2127. doi: 10.1073/pnas.73.6.2123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Costanza M. E., Pinn V., Schwartz R. S., Nathanson L. Carcinoembryonic antigen-antibody complexes in a patient with colonic carcinoma and nephrotic syndrome. N Engl J Med. 1973 Sep 6;289(10):520–522. doi: 10.1056/NEJM197309062891007. [DOI] [PubMed] [Google Scholar]
  3. Fuks A., Banjo C., Shuster J., Freedman S. O., Gold P. Carcinoembryonic antigen (CEA): molecular biology and clinical significance. Biochim Biophys Acta. 1975 Jul 11;417(2):123–152. doi: 10.1016/0304-419x(75)90002-5. [DOI] [PubMed] [Google Scholar]
  4. Gold J. M., Gold P. The blood group A-like site on the carcinoembryonic antigen. Cancer Res. 1973 Nov;33(11):2821–2824. [PubMed] [Google Scholar]
  5. Greenberg A. H., Shen L., Roitt I. M. Characterization of the antibody-dependent cytotoxic cell. A non-phagocytic monocyte? Clin Exp Immunol. 1973 Oct;15(2):251–259. [PMC free article] [PubMed] [Google Scholar]
  6. Halloran P., Schirrmacher V., Festenstein H. A new sensitive assay for antibody against cell surface antigens based on inhibition of cell-dependent antibody-mediated cytotoxicity. I. Specificity and sensitivity. J Exp Med. 1974 Nov 1;140(5):1348–1363. doi: 10.1084/jem.140.5.1348. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Lo Gerfo P., Herter F. P., Bennett S. J. Absence of circulating antibodies to carcinoembryonic antigen in patients with gastrointestinal malignancies. Int J Cancer. 1972 Mar 15;9(2):344–348. doi: 10.1002/ijc.2910090212. [DOI] [PubMed] [Google Scholar]
  8. MacLennan I. C. Competition for receptors for immunoglobulin on cytotoxic lymphocytes. Clin Exp Immunol. 1972 Feb;10(2):275–283. [PMC free article] [PubMed] [Google Scholar]
  9. Shoham J., Cohen M. Antibody-dependent cellular cytotoxicity to human colon-tumour cells. I. Lack of tumour specificity in a population study. Br J Cancer. 1979 Aug;40(2):234–243. doi: 10.1038/bjc.1979.171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Wang A. C., Banjo C., Fuks A., Shuster J., Gold P. Heterogeneity of the protein moiety of carcinoembryonic antigens. Immunol Commun. 1976;5(3):205–210. doi: 10.3109/08820137609044276. [DOI] [PubMed] [Google Scholar]
  11. von Kleist S. Substances immunologically related to CEA. Ann Immunol (Paris) 1973 Nov;124(4):589–593. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES